文献速递结核与非结核分枝杆菌细菌感染、耐药与抗菌药物

耐药结核治疗依从性轨迹分型:群体轨迹模型应用

Characterizing Treatment Adherence Trajectories in the endTB Multisite Cohort of Drug-Resistant Tuberculosis Patients: An Application of Group-Based Trajectory Modeling.
PubMed 文献 · Clin Infect Dis · 2026-01-01

基于endTB多中心观察队列1787例耐多药/利福平耐药结核患者,采用联合潜类别混合模型识别出4种治疗依从性轨迹。初始依从性差但随后改善者临床结局与持续高依从者相当,轨迹模型预测结局优于80%阈值等常规分类方法。

要点

  • 识别出持续高、高转低、低转高、持续低4种依从性轨迹。
  • 高转低与持续低者治疗失败风险显著升高,低转高者未升高。
  • 轨迹模型预测结局准确性优于80%依从阈值等常规方法。

核心结论

  • 群体轨迹模型比常规分类方法更能细致刻画RR/MDR-TB治疗依从性模式。
  • 初始依从性差但后续改善者的临床结局与持续高依从者相当。
  • 依从性轨迹模式而非总体依从率可能更能预测RR/MDR-TB临床结局。

研究设计与样本

  • endTB观察性研究多中心队列,纳入1787例接受RR/MDR-TB治疗者。
  • 应用联合潜类别混合模型分类依从性轨迹并评估其与治疗结局的关系。
  • 以Kendall τb和预测不良结局的ROC曲线下面积比较轨迹模型与80%依从阈值等常规分类方法。

主要发现

  • 4种依从性轨迹占比:持续高72.5%、高转低14.3%、低转高7.3%、持续低5.9%。
  • 以持续高依从为参照,高转低组不良结局风险HR=23.2(95%CI 15.7-24.3)。
  • 持续低依从组不良结局风险HR=43.2(95%CI 26.2-71.5)。

关键数值与推荐

  • 常规依从性评估常用80%阈值,可能遗漏有意义的依从模式。

临床怎么用

  • RR/MDR-TB治疗管理可考虑用轨迹模型识别依从性模式而非仅看总体依从率。
  • 对高转低和持续低依从轨迹患者应重点识别并加强干预。
  • 初始依从性差但后续改善者结局可与持续高依从者相当,不宜仅因早期依从差而否定治疗前景。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In tuberculosis (TB) care, adherence is often assessed using a simple 80% threshold, which may overlook meaningful patterns. We analyzed adherence trajectories among individuals treated for rifampicin- or multidrug-resistant TB (RR/MDR-TB) in the endTB observational study to identify more informative patterns. METHODS: We applied a joint latent class mixed model to classify adherence trajectories and assess their relationship with treatment outcomes. Model performance was compared to common classification methods (eg 80% adherence threshold) using Kendall's τb and area under the receiver operating curve for predicting unsuccessful outcomes. RESULTS: Among 1787 individuals, we identified 4 adherence patterns: "consistently high" (72.5%), "high to low" (14.3%), "low to high" (7.3%), and "consistently low" (5.9%). Compared to the "consistently high" group, those in "high to low" (hazard ratio [HR] = 23.2; 95% confidence interval [CI]: 15.7-24.3) and "consistently low" (HR = 43.2; 95% CI: 26.2-71.5) groups had significantly higher risk of unsuccessful outcomes, while the "low to high" group did not (HR = 0.7; 95% CI: .1-3.8). Our trajectory model more accurately predicted outcomes than common classification methods (P < .01). CONCLUSIONS: Group-based trajectory modeling provides more nuanced insights into adherence patterns than conventional classification methods. Our findings demonstrate that patients with RR/MDR-TB who exhibited initial poor adherence followed by subsequent improvement achieved clinical outcomes comparable to those with consistently high adherence throughout treatment. This finding challenges the prevailing assumption that sustained high adherence is necessary for treatment success, suggesting that adherence patterns, rather than overall adherence rates, may be more predictive of clinical outcomes in the management of RR/MDR-TB.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Law S, Fulcher I, Ashraf S, et al. Characterizing Treatment Adherence Trajectories in the endTB Multisite Cohort of Drug-Resistant Tuberculosis Patients: An Application of Group-Based Trajectory Modeling. Clin Infect Dis. 2026. PMID: 40843468. doi:10.1093/cid/ciaf467

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。